• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
DONG Lili,WU Suling,MA Chunhua,LONG Hongyan,SHAN Minghui.Effect of Bitong Mixture on synovial tissue in rats with adjuvant arthritis[J].Journal Of Pharmaceutical Research,2019,38(8):449-452[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3264times   Download 3339次 QR Code for this article
Scan with your phone!
痹痛合剂对佐剂性关节炎大鼠滑膜组织的影响
董莉莉,吴素玲,马春华,隆红艳,沙明慧
Font:Larger+|Default|Smaller-
(南京中医药大学实验动物中心,江苏 南京 210000)
摘要:
目的 考察痹痛合剂通过NF-κB信号通路对佐剂性关节炎大鼠关节滑膜炎症的调节。方法 将40只SD大鼠随机分成5组,分别为:空白组,模型组,双氯芬酸钠组,痹痛合剂高剂量组(高剂量组)、痹痛合剂低剂量组(低剂量组),除正常组外,其余大鼠采用0.2 mL弗氏完全佐剂皮内注射右后足趾,形成佐剂性关节炎大鼠模型。正常组注射等体积的生理盐水在相同部位注射。致炎后,每组大鼠根据设定剂量连续灌胃给药21 d,双氯芬酸钠组每天剂量为0.5 mg·(100 g)-1双氯芬酸钠,痹痛合剂高剂量组每天剂量为0.6 mL·(100 g)-1痹痛合剂,低剂量组每天剂量为0.3 mL·(100 g)-1痹痛合剂。分别给予空白组、模型组等体积的蒸馏水。检测大鼠滑膜组织病理组织学改变,炎症因子核因子-κB (NF-κB)、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、肿瘤坏死因子α(TNF-α)的表达水平改变及核因子-κB信号通路相关蛋白的相对表达水平改变。结果 各给药组在以上各检测指标上较模型组有显著改变(P<0.01),痹痛合剂高剂量组的治疗作用优于低剂量组和双氯芬酸钠组(P<0.05)。结论 痹痛合剂具有抑制关节滑膜组织中炎症因子的表达,可有效减轻佐剂性关节炎大鼠的关节炎症表现。
关键词:  痹痛合剂  类风湿关节炎  炎症因子  核因子-κB  白细胞介素-1β  白细胞介素-6  肿瘤坏死因子α
DOI:10.13506/j.cnki.jpr.2019.08.003
基金项目:江苏省中医药管理局项目(No.YB201825)
Effect of Bitong Mixture on synovial tissue in rats with adjuvant arthritis
DONG Lili,WU Suling,MA Chunhua,LONG Hongyan,SHAN Minghui
(Laboratory Animal Center,Nanjing University of Traditional Chinese Medicine,Nanjing 210000,China)
Abstract:
Objective To investigate the regulation of Bitong Mixture on synovitis in adjuvant arthritis rats through NF-kappa B signaling pathway.Methods Forty SD rats were randomly divided into five groups: blank group, model group, diclofenac sodium group, Bitong mixture high dose group (high dose group), Bitong mixture low dose group (low dose group). Except the normal group, the other rats were injected with 0.2 mL Freund's complete adjuvant intradermally into the right hind toe to form an adjuvant-induced arthritis rat model. The normal group was injected with saline of equal volume at the same place. After inflammation, rats in each group were given continuous intragastric administration for 21 days according to the set dose. The daily dose of diclofenac sodium group was 0.5 mg·(100 g)-1 diclofenac sodium, the daily dose of Bitong mixture in high dose group was 0.6 mL·(100 g)-1 Bitong mixture, and the daily dose of Bitong mixture in low dose group was 0.3 mL/100g Bitong mixture. Distilled water of equal volume was given to blank group and model group respectively. The histopathological changes of synovium, the expression levels of inflammatory factors such as NF-kB, IL-1beta, IL-6, TNF-alpha and the relative expression levels of NF-kappa B signaling pathway related proteins were detected.Results There were significant changes in the above indicators in each group compared with the model group (P<0.01). The therapeutic effect of Bitong Mixture high dose group was better than that of low dose group and diclofenac sodium group (P<0.05).Conclusion Bitong Mixture can inhibit the expression of inflammatory factors in synovial tissue of joint, and can effectively reduce the expression of arthritis in adjuvant arthritis rats.
Key words:  Bitong mixture  Rheumatoid arthritis  Inflammatory factor  NF-kappa B  IL-1 β  IL-6  TNF-α
Today's Visits:483    Total Visits:2383194
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.